
Sanofi has partnered with Translate Bio to develop a novel messenger RNA (mRNA) vaccine for COVID-19 while they are also …

The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …

The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …

Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …

The US Department of Health and Human Services (HHS) has said it will fund the production of MSD’s investigational Ebola …

Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …

Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases …

Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …

Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …

Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …

England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …

The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson’s …

Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …

The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …